Vericel (VCEL) Other Working Capital Changes (2010 - 2026)
Vericel's (VCEL) quarterly Other Working Capital Changes came in at $246000.0 in Q1 2026, down 80.02% year-on-year from $1.2 million in Q1 2025, and up 193.89% quarter-over-quarter from -$262000.0 in Q4 2025.
Vericel (VCEL) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Vericel has disclosed Other Working Capital Changes across 17 years of filings, most recently posting $246000.0 for Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at $246000.0, down 80.02% year-over-year; the trailing twelve-month figure through Mar 2026 was -$528000.0 (down 171.06% YoY), and the FY2025 annual result was $457000.0, up 5.3% from the prior year.
- Other Working Capital Changes came in at $246000.0 for Q1 2026 at Vericel, up from -$262000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.4 million in Q3 2024 to a low of -$1.9 million in Q2 2025.
- The 5-year median for Other Working Capital Changes is $386000.0 (2023), against an average of $201588.2.
- Peak annual rise in Other Working Capital Changes reached 450.57% in 2024, while the deepest fall reached 366.47% in 2024.
- Vericel's Other Working Capital Changes stood at $393000.0 in 2022, then jumped by 181.42% to $1.1 million in 2023, then slumped by 153.8% to -$595000.0 in 2024, then soared by 55.97% to -$262000.0 in 2025, then surged by 193.89% to $246000.0 in 2026.
- The last three Other Working Capital Changes figures came in at $246000.0 (Q1 2026), -$262000.0 (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 246,000.00 |
| Mar 31, 2026 | 246,000.00 |
| Dec 31, 2025 | -262,000.00 |
| Dec 31, 2025 | -262,000.00 |
| Sep 30, 2025 | 1.43 Mn |
| Sep 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | -1.94 Mn |
| Jun 30, 2025 | -1.94 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Dec 31, 2024 | -595,000.00 |
| Dec 31, 2024 | -595,000.00 |
| Sep 30, 2024 | 1.45 Mn |
| Sep 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | -1.34 Mn |
| Jun 30, 2024 | -1.34 Mn |
| Mar 31, 2024 | 922,000.00 |
| Mar 31, 2024 | 922,000.00 |
| Dec 31, 2023 | 1.11 Mn |
| Dec 31, 2023 | 1.11 Mn |